Table 4.
Sequencea | MH+ | Charge | XCorr |
---|---|---|---|
122FF K~ FSRDVFLP K~ PSWGNHTIPF 148R | 3017.23 | 3 | 2.47 |
242H FIEQGINV C@ LCQSYA K^ N M* GLYGE 266R | 3077.29 | 3 | 2.95 |
267VGAFTVV C@ KDAEEAK 282R | 1808.91 | 3 | 3.12 |
55K AEAQIAGKNLD K~ EYLPIGGLADF C# 81K | 2945.47 | 3 | 4.03 |
64NLD K~ EYLPIGGLADF C# 81K | 2048.96 | 2 | 2.41 |
288K~ ILIRPLYSNNPLNGA 304R | 2730.51 | 3 | 2.53 |
283VESQL K~ ILIRPLYSNNPLNGA 304R | 2574.40 | 3 | 3.13 |
160YYDP K~ T C# GFDFSGALEDIS 179K | 2409.02 | 2 | 2.79 |
3ASSWWTHVEMGPPDPILGVTEAF 25K~ | 2907.30 | 3 | 3.35 |
Following trypsin treatment of a control (untreated) and TFEC-modified protein, the peptide mixture was analyzed on-line on a LTQ FT mass spectrometer, as indicated in the text. TFEC-modified residues are highlighted in bold face.